Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Learning to beat cancer pain: new program shows promise

NCT ID NCT03297723

Symptom relief Sponsor: Centre Francois Baclesse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a patient education program for 167 cancer patients with moderate to severe pain. The program included identifying patient needs, setting goals, and tailored learning activities. Researchers measured whether the program reduced how much pain interfered with daily life, comparing it to standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
patient therapeutic education program
What this could lead to
If successful, this program could become a standard way to help cancer patients manage pain and improve their quality of life.
What could go wrong
This is a completed study with 167 participants, so results are limited. The program may not work for everyone, and benefits depend on patient engagement and training quality.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

167 people

The number who actually took part.

Started

Dec 2017

Finished

Jan 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient suffering from a cancer and suffering from pain

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient suffering from a cancer which diagnosis has been established since at least 1 month * Patient who suffers from pain related to the pathology or its treatment: * receiving an analgesic treatment since at least 1 month * moderate to severe pain intensity in the previous week : average pain score greater than 4 (on a 0-10 numerical rating scale), OR pain leading to insomnia OR 4 daily breakthrough pain, which interferes with daily activities * Patient with a life expectancy \> or = 6 months * Health compatible with the PEP requirements (WHO performance scale \> or = 2) * Patient v 18 years old * Patient able to understand, speak and read French * Patient without cognitive dysfunctions * Patient with a signed informed consent before inclusion in the study Exclusion Criteria: * Primary central nervous system or cerebral metastases * Disorders of higher functions documented * Evolutionary psychiatric pathology * Drug user * Abuse of alcohol exceeding WHO recommendations * Refusal of participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Cancer Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pain cancer

Contacts and locations

Locations

  • CHU CAEN

    Caen, France

  • Centre François Baclesse

    Caen, France

  • Centre Hospitalier AVRANCHES-GRANVILLE

    Avranches, France

  • Centre Hospitalier Bayeux

    Bayeux, France

  • Centre Hospitalier Lisieux

    Lisieux, France

  • Centre Hospitalier d'Argentan

    Argentan, France

  • Centre Hospitalier de Cherbourg

    Cherbourg-Octeville, France

  • Centre Hospitalier de Flers

    Flers, France

  • Centre Hospitalier de Saint-lo

    Saint-Lô, France

  • Centre Oscar Lambret

    Lille, France

  • Ch Dieppe

    Dieppe, France

  • Ghpso Senlis

    Senlis, France

  • Hopital Européen Georges Pompidou (HEGP)

    Paris, France

  • Hopital privé Paul d'Egine

    Champigny-sur-Marne, France

  • IGR

    Villejuif, France

  • centre Hospitalier d'Alençon

    Alençon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.